Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-04-23

FDA Approved: RUFINAMIDE — Original Application (Bionpharma Inc.)

View source ↗

Summary

The FDA approved an original application for a generic version of Rufinamide by Bionpharma Inc. for use in treating seizures associated with Lennox-Gastaut synd…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rufinamide (Rufinamide)

Snippet

ORIG AP for RUFINAMIDE (RUFINAMIDE)